Rose DiMartino - 16 Jul 2024 Form 4 Insider Report for abrdn Life Sciences Investors (HQL)

Role
Director
Signature
/s/ Katherine Corey, as attorney-in-fact for Rose DiMartino
Issuer symbol
HQL
Transactions as of
16 Jul 2024
Net transactions value
+$15,530
Form type
4
Filing time
18 Jul 2024, 14:56:19 UTC
Previous filing
23 May 2024
Next filing
04 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQL Common Stock Purchase $15,530 +1,000 $15.53 1,000 16 Jul 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.